The Qingrehuoxue formula has been found to inhibit NSCLC tumorigenesis by activating both ferroptosis and apoptosis through the p53 and GSK-3/NRF2 signaling pathways [45]. This evidence concerns the gene TP53 and non-small cell lung carcinoma.